AngioDynamics traded at $11.44 this Friday February 27th, decreasing $0.02 or 0.17 percent since the previous trading session. Looking back, over the last four weeks, AngioDynamics lost 14.29 percent. Over the last 12 months, its price rose by 23.14 percent. Looking ahead, we forecast AngioDynamics to be priced at 10.87 by the end of this quarter and at 9.89 in one year, according to Trading Economics global macro models projections and analysts expectations.
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.